D'Arcangelo · Antioxidants (Basel, Switzerland) 2026 · narrative review · n=?

Oxidative Stress and Alcohol-Related Hepatitis: A Role for Future Therapies.

Cited 1 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of molecular mechanisms and therapeutic targets with no original human data

PubMed 42072135 · doi:10.3390/antiox15040493 · record verified 2026-08-31

What was done

This narrative review synthesized literature on the molecular crosstalk between oxidative stress, inflammatory signaling (including TLR pathways, Kupffer cell activation, and neutrophil NETosis), hepatocyte cell death modalities, and therapeutic approaches in alcohol-associated hepatitis.

What was found

The abstract reports no numerical data or effect sizes. It summarizes biological pathways involving ethanol-induced reactive oxygen species production (CYP2E1 induction, mitochondrial dysfunction, and NADPH oxidase activation) leading to cellular damage and varied cell death forms (apoptosis, necroptosis, pyroptosis, ferroptosis), noting that corticosteroids remain standard first-line treatment while emerging agents target the gut-liver axis and liver regeneration.

Why it matters

Alcohol-associated hepatitis carries severe morbidity with limited therapeutic options. Delineating interconnected oxidative and inflammatory mechanisms helps clarify biological rationales for novel investigational drugs.

Limits

This is a narrative review with no systematic search methodology, meta-analysis, or quality appraisal. No original clinical or experimental patient data are reported in the abstract.

Cited by